APA (7th ed.) Citation

Pikarsky, E., Elia, A., Dinstag, G., Tirosh, O., Beker, T., Aharonov, R., . . . Blumenfeld, P. Predictive value of ENLIGHT-DP in patients with metastatic lung adenocarcinoma treated with immune checkpoint inhibitors and platinum chemotherapy directly from histopathology slides using inferred transcriptomics. BMJ Publishing Group.

Chicago Style (17th ed.) Citation

Pikarsky, Eli, et al. Predictive Value of ENLIGHT-DP in Patients with Metastatic Lung Adenocarcinoma Treated with Immune Checkpoint Inhibitors and Platinum Chemotherapy Directly from Histopathology Slides Using Inferred Transcriptomics. BMJ Publishing Group.

MLA (9th ed.) Citation

Pikarsky, Eli, et al. Predictive Value of ENLIGHT-DP in Patients with Metastatic Lung Adenocarcinoma Treated with Immune Checkpoint Inhibitors and Platinum Chemotherapy Directly from Histopathology Slides Using Inferred Transcriptomics. BMJ Publishing Group.